27 June 2016 – final results

The medical diagnostics company has produced its final results for the year to 31 March which have revealed a 5% increase in turnover to £12.7m (2015: £12.1m) whilst adjusted pre-tax profits came out at a similar level at £1.35m (2015: £1.37m).  Adjusted earnings per share fell to 1.2p (2015: 1.3p) and the group ended the period with net cash of £1.30m (2015: £1.97m).  These results demonstrate that the company has made steady progress during the year mainly driven by the food intolerance division.  This progress is expected to continue whilst there are also opportunities in the allergy business.  The shares remain a LONG TERM BUY.